279 related articles for article (PubMed ID: 23917010)
21. High incidence of tachyarrhythmias detected by an implantable loop recorder in patients with unexplained syncope.
Schernthaner C; Danmayr F; Altenberger J; Pichler M; Strohmer B
Kardiol Pol; 2008 Jan; 66(1):37-44; discussion 45-6. PubMed ID: 18266186
[TBL] [Abstract][Full Text] [Related]
22. [Indications for implantable loop recorders in patients with channelopathies and ventricular tachycardias].
Köbe J; Wasmer K; Reinke F; Eckardt L
Herzschrittmacherther Elektrophysiol; 2016 Dec; 27(4):360-365. PubMed ID: 27844191
[TBL] [Abstract][Full Text] [Related]
23. [Catecholaminergic polymorphic ventricular tachycardia in adult: a case report].
Ben Ameur Y; Kamoun S; Ben Moussa F; Battikh K; Longo S; Ben Youssef I; Slimane ML
Tunis Med; 2010 May; 88(5):349-52. PubMed ID: 20517833
[TBL] [Abstract][Full Text] [Related]
24. Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias.
Volosin K; Stadler RW; Wyszynski R; Kirchhof P
Europace; 2013 Aug; 15(8):1215-22. PubMed ID: 23439867
[TBL] [Abstract][Full Text] [Related]
25. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study.
Da Costa A; Defaye P; Romeyer-Bouchard C; Roche F; Dauphinot V; Deharo JC; Jacon P; Lamaison D; Bathélemy JC; Isaaz K; Laurent G
Arch Cardiovasc Dis; 2013 Mar; 106(3):146-54. PubMed ID: 23582676
[TBL] [Abstract][Full Text] [Related]
26. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia.
Celiker A; Erdoğan I; Karagöz T; Ozer S
Cardiol Young; 2009 Feb; 19(1):45-52. PubMed ID: 19102802
[TBL] [Abstract][Full Text] [Related]
27. Ventricular tachycardia recorded in a competitive swimmer using Confirm Rx™ loop recorder.
Yoon JG; Snyder CS; Hoyt WJ
Cardiol Young; 2020 Mar; 30(3):438-440. PubMed ID: 32036810
[TBL] [Abstract][Full Text] [Related]
28. The Beneficial Role of Telemedicine for Arrhythmic Risk Stratification in Asymptomatic Brugada Syndrome: An Exemplary Case Report.
Santobuono VE; Carella MC; Guaricci AI; Carulli E; Basile P; Dicorato MM; Ciccone MM; Forleo C
Telemed J E Health; 2024 May; 30(5):1499-1503. PubMed ID: 38294864
[No Abstract] [Full Text] [Related]
29. Right bundle branch block, intermittent ST segment elevation and inducible ventricular tachycardia in an asymptomatic patient: an unusual presentation of the Brugada syndrome?
Bertaglia E; Michieletto M; Spedicato L; Pascotto P
G Ital Cardiol; 1998 Aug; 28(8):893-8. PubMed ID: 9773315
[TBL] [Abstract][Full Text] [Related]
30. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children].
Ge HY; Li XM; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li MT
Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):926-931. PubMed ID: 29262473
[No Abstract] [Full Text] [Related]
31. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Rosso R; Kalman JM; Rogowski O; Diamant S; Birger A; Biner S; Belhassen B; Viskin S
Heart Rhythm; 2007 Sep; 4(9):1149-54. PubMed ID: 17765612
[TBL] [Abstract][Full Text] [Related]
32. [Long term results of implantable loop recorder in patients with syncope: results of a French survey].
Amara W; Sileu N; Salih H; Sergent J; Monsel F
Ann Cardiol Angeiol (Paris); 2014 Nov; 63(5):327-30. PubMed ID: 25281994
[TBL] [Abstract][Full Text] [Related]
33. Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience.
Scrocco C; Ben-Haim Y; Devine B; Tome-Esteban M; Papadakis M; Sharma S; Macfarlane PW; Behr ER
Heart Rhythm; 2022 Jan; 19(1):70-78. PubMed ID: 34487893
[TBL] [Abstract][Full Text] [Related]
34. Artefact mimicking tachycardia during magnetic resonance imaging in a patient with an implantable loop recorder.
Gimbel JR; Wilkoff BL
Heart; 2003 Mar; 89(3):e10. PubMed ID: 12591861
[TBL] [Abstract][Full Text] [Related]
35. [Implantable event recorder: a new aid for the diagnosis of arrhythmogenic syncope].
Müller U; Jochheim R; Knaup W; Tenholt M
Dtsch Med Wochenschr; 1998 Nov; 123(46):1378-82. PubMed ID: 9842398
[TBL] [Abstract][Full Text] [Related]
36. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
Karaca M; Dinckal MH
Acta Cardiol; 2006 Aug; 61(4):481-4. PubMed ID: 16970061
[TBL] [Abstract][Full Text] [Related]
37. Catecholaminergic Polymorphic Ventricular Tachycardia.
Wall JJ; Iyer RV
Pediatr Emerg Care; 2017 Jun; 33(6):427-431. PubMed ID: 28570361
[TBL] [Abstract][Full Text] [Related]
38. Value and limitations of noninvasive assessment of syncope.
Hammill SC
Cardiol Clin; 1997 May; 15(2):195-218. PubMed ID: 9164710
[TBL] [Abstract][Full Text] [Related]
39. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
Pflaumer A; Davis AM
Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737
[TBL] [Abstract][Full Text] [Related]
40. [Catecholaminergic polymorphic ventricular tachycardia].
Leren IS; Haugaa KH; Edvardsen T; Anfinsen OG; Kongsgård E; Berge KE; Leren TP; Amlie JP
Tidsskr Nor Laegeforen; 2010 Jan; 130(2):139-42. PubMed ID: 20125202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
